Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 688-332-8 | CAS number: 199119-58-9
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 6 May 1997 to 20 May 1997
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was performed to GLP and in line with standardised guidelines OECD 402, EU Method B.3 and EPA OPP 81-2 with no deviations thought to impact on the reliability of the presented results.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- yes
- Remarks:
- A limit dose of 5000 mg/kg was used, this is not considered to impact on the validity of the results.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- yes
- Remarks:
- A limit dose of 5000 mg/kg was used, this is not considered to impact on the validity of the results.
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-2 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: J-MAFF 59 NohSan No. 4200
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- sodium 4,6-dimethoxy-N-({[3-(2,2,2-trifluoroethoxy)pyridin-2-yl]sulfonyl}carbamoyl)pyrimidin-2-aminide
- EC Number:
- 688-332-8
- Cas Number:
- 199119-58-9
- Molecular formula:
- C14H13F3N5O6SNa
- IUPAC Name:
- sodium 4,6-dimethoxy-N-({[3-(2,2,2-trifluoroethoxy)pyridin-2-yl]sulfonyl}carbamoyl)pyrimidin-2-aminide
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Physical state: solid (powder)
- Storage condition of test material: room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: TIF:RAIf
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: approximately 8 weeks
- Weight at study initiation: 202 - 246 g g
- Housing: animals were housed individually
- Diet: commercial diet available ad libitum
- Water: municipal water available ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 2 °C
- Humidity (%): 55 ± 10 %
- Air changes: approximately 13-14 air changes per hour
- Photoperiod: 12 hours dark / 12 hours light
IN-LIFE DATES: From 6 May 1997 to 20 May 1997
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- water
- Details on dermal exposure:
- TEST SITE
- Area of exposure: the back of each animal (4 cm x 5 cm area, 10% of body surface) was clipped free of hair with electric clippers to allow administration of the test material.
- Type of wrap if used: The test material was evenly applied to the shorn back of each animal and was kept in contact with the skin for approximately 24 hours using a semiocclusive dressing wrapped around the trunk. Each dressing consisted of a gauze patch to cover the treated area and was held in place by a adhesive bandage.
REMOVAL OF TEST SUBSTANCE
- Washing: The skin at the site of application was cleansed of any residual test material with lukewarm water
- Time after start of exposure: At the end of the 24 hour contact period.
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 5.0 g test material in 10.0 mL of distilled water. 0.4 mL was applied per 100 g bodyweight. The amount of test material applied was calculated for each animal according to its weight at the time of dosing. - Duration of exposure:
- 24 hours
- Doses:
- 0 (vehicle control), 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: All animals were checked twice daily for mortality, morning and afternoon. Clinical observations were recorded individually within the first hour after dosing, then daily for the duration of the observation period. The application site was examined daily for signs of dermal irritation. Bodyweights were recorded immediately before dose administration and then on day 7 and day 14.
- Necropsy of survivors performed: All animals were killed by CO2 asphyxiation and subjected to a necropsy examination.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No mortality was noted in either sex
- Mortality:
- No animals died during the study.
- Clinical signs:
- other: There were no remarkable clinical observations for any animals in either dose group.
- Gross pathology:
- Necropsy examinations revealed no observable abnormalities.
- Other findings:
- There were no remarkable findings at the application site for any animal.
Any other information on results incl. tables
Table 2: Bodyweights (g)
Dose group |
Animal |
Day 0 |
Day 7 |
Day 14 |
Animal |
Day 0 |
Day 7 |
Day 14 |
Females |
Males |
|||||||
2000 mg/kg |
101 |
203.7 |
219.3 |
226.2 |
1 |
230.9 |
272.0 |
317.7 |
102 |
202.8 |
203.8 |
220.3 |
2 |
241.0 |
286.6 |
325.4 |
|
103 |
218.6 |
229.8 |
244.0 |
3 |
232.8 |
270.7 |
307.0 |
|
104 |
202.6 |
209.8 |
230.9 |
4 |
215.4 |
251.0 |
309.2 |
|
105 |
203.0 |
211.1 |
233.9 |
5 |
227.7 |
270.5 |
310.2 |
|
Mean |
206.1 |
214.8 |
231.1 |
Mean |
229.6 |
270.2 |
313.9 |
|
SD |
7.0 |
10.1 |
8.9 |
SD |
9.3 |
12.7 |
7.6 |
|
0 mg/kg |
106 |
206.3 |
209.6 |
220.3 |
6 |
226.1 |
256.5 |
290.2 |
107 |
206.6 |
215.5 |
228.4 |
7 |
222.3 |
256.7 |
290.0 |
|
108 |
209.3 |
210.2 |
225.0 |
8 |
246.4 |
276.2 |
310.8 |
|
109 |
201.8 |
204.4 |
222.6 |
9 |
224.9 |
257.5 |
303.7 |
|
110 |
229.1 |
234.9 |
249.9 |
10 |
226.1 |
256.6 |
295.4 |
|
Mean |
210.4 |
214.9 |
229.2 |
Mean |
229.2 |
260.7 |
298.0 |
|
SD |
10.8 |
11.8 |
11.9 |
SD |
9.7 |
8.7 |
9.0 |
|
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of the test, the acute dermal median lethal dose of the test material was estimated to be in excess of 2000 mg/kg in male and female rats. The study is considered to be reliable, relevant and adequate for risk assessment and classification and labelling purposes.
- Executive summary:
The acute dermal toxicity of the test material was determined in accordance with standardised guidelines OECD 402, EU Method B.3 and EPA OPP 81 -2. During the study, five male and female rats received a single dermal application of 2000 mg/kg of the test material and were assessed daily for the following 14 days for any signs of systemic toxicity. None of the animals died and there were no signs of systemic toxicity. All animals gained weight during the study. There were no macroscopic abnormalities at examination post mortem. The acute dermal median lethal dose of the test material was estimated to be in excess of 2000 mg/kg to both male and female rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
